Featured Videos

With a view toward injecting some modicum of clarity into the volatile arena of NIL, a plethora of legislation has been enacted at the state level and proposed at the federal level.        

Just two months after being targeted by the Department of Justice, Apple was hit with a fresh lawsuit in the Northern District of California alleging anti-competitive practices and lost a bid to block a class action in the U.S. Court of Appeals for the Ninth Circuit.        

“Government contractors should assume that the DOJ and FBI are listening to communications with competitors,” said Dylan Carson, a partner at Manatt, Phelps & Phillips.        

“I know I missed many excellent applicants,” wrote David Tatel, who served on the U.S. Court of Appeals for the District of Columbia Circuit.       Related Stories’Indefensible & Inexcusable’: Ex-Judge Luttig on Role of Lawyers in Lead Up to Jan. 6 – EnclosureJudges in the Hot Seat Over Oral Argument Diversity Policies – Enclosure’Watershed Moment’: Female […]

On Thursday, the U.S. Judicial Panel on Multidistrict Litigation heard arguments on whether to combine about two dozen lawsuits alleging children and young adults got addicted to video games.        

The 15 people who were arrested, which includes seven students, were due to be arraigned June 4 in Amherst Town Court.        

Trump, 77, was found guilty of 34 counts of falsifying business records. Prosecutors persuaded the jury that he conspired with others to “catch and kill” negative stories about himself during the 2016 presidential election cycle, thereby unlawfully influencing the election.        

The trial court ruled it was barred by “act of state doctrine,” which, prohibits American courts from sitting in judgment on the acts of another government acting within its own territory.        

The verdict is expected to be read shortly. Trump, 77, is charged with 34 counts of falsifying business records. Prosecutors claim he conspired with others to “catch and kill” negative stories about himself during the 2016 presidential election cycle, thereby unlawfully influencing the election.        

Five of the suits were filed by Esperion Therapeutics, which seeks to stop competitors from selling generic versions of the company’s cholesterol drug Nexletol.